The anti-cocaine vaccine, developed by researchers at the Federal University of Minas Gerais, Brazil, aims to produce antibodies that bind to cocaine when it is taken. This would make it harder for the substance to pass through the bloodstream to the brain. The vaccine would try to inhibit the brain reactions that trigger the craving.
Latest News
20:28
The Trump administration spent $9.5 billion on paid leave granted to federal employees
20:24
Italy’s government will abolish the vehicle tax from 2027 for 14.5 million vehicles
20:19
Rafael Nadal will play in front of the public again on October 3 at his academy in Manacor
20:09
Foreign Ministry investigates closure of Romanian-language class in Ukraine / Odesa Consulate to discuss the case on September 18
19:57
The Bucharest Court of Appeal annulled the ANRE fine imposed on Tinmar Energy for allegedly manipulating the energy market
See more news